Modification of Huntington's disease by short tandem repeats

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• Expansions of CAG trinucleotide repeats cause neurodegenerative polyglutamine diseases.
• Age-at-onset in these diseases generally correlates inversely with the size of the expanded CAG repeat.
• Somatic instability of expanded CAG repeats and DNA maintenance genes influence Huntington's disease onset.

Purpose of the Study:

• To investigate if CAG repeat lengths in other polyglutamine disease genes modify age-at-onset in Huntington's disease.
• To explore the role of other polyglutamine disease genes as potential modifiers of Huntington's disease residual age-at-onset.

Main Methods:

• Analysis of CAG repeat sizes in polymorphic genes within Huntington's disease patient cohorts.
• Genome-wide association studies (GWAS) using single nucleotide polymorphism (SNP) data.
• GWAS utilizing imputed short tandem repeat (STR) data to identify genetic modifiers.

Main Results:

• CAG repeat sizes of other polyglutamine disease genes did not influence Huntington's disease age-at-onset.
• Specific analysis of ATXN3 CAG repeat length in a large cohort (n=1388) confirmed no association with residual age-at-onset.
• GWAS data did not support the involvement of other polyglutamine disease genes in modifying Huntington's disease onset.

Conclusions:

• Huntington's disease age-at-onset is not modified by the CAG repeat lengths of other known polyglutamine disease genes.
• Genome-wide association studies reveal significant modification signals from STRs in genomic regions unrelated to other polyglutamine disease genes.
• These findings refine the understanding of Huntington's disease genetic modifiers and emphasize rigorous analysis in genetic studies.